Paloma Partners Management Co cut its stake in shares of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) by 68.8% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 80,322 shares of the software maker’s stock after selling 176,920 shares during the period. Paloma Partners Management Co’s holdings in Allscripts Healthcare Solutions were worth $1,018,000 at the end of the most recent quarter.

A number of other large investors have also made changes to their positions in MDRX. Vanguard Group Inc. raised its stake in shares of Allscripts Healthcare Solutions by 3.7% in the first quarter. Vanguard Group Inc. now owns 14,642,919 shares of the software maker’s stock valued at $185,672,000 after buying an additional 519,798 shares during the period. Dimensional Fund Advisors LP raised its stake in shares of Allscripts Healthcare Solutions by 9.4% in the first quarter. Dimensional Fund Advisors LP now owns 7,227,789 shares of the software maker’s stock valued at $91,648,000 after buying an additional 621,620 shares during the period. Fiduciary Management Inc. WI raised its stake in shares of Allscripts Healthcare Solutions by 28.5% in the first quarter. Fiduciary Management Inc. WI now owns 6,045,110 shares of the software maker’s stock valued at $76,652,000 after buying an additional 1,341,870 shares during the period. First Trust Advisors LP raised its stake in shares of Allscripts Healthcare Solutions by 48.0% in the first quarter. First Trust Advisors LP now owns 5,855,944 shares of the software maker’s stock valued at $74,253,000 after buying an additional 1,898,007 shares during the period. Finally, Boston Partners raised its stake in Allscripts Healthcare Solutions by 12.0% in the first quarter. Boston Partners now owns 4,648,327 shares of the software maker’s stock valued at $58,941,000 after buying an additional 498,267 shares during the last quarter.

Allscripts Healthcare Solutions, Inc. (MDRX) traded down 2.10% on Thursday, reaching $11.67. 3,573,442 shares of the company’s stock were exchanged. The company’s market cap is $2.12 billion. Allscripts Healthcare Solutions, Inc. has a 52 week low of $9.80 and a 52 week high of $15.17. The stock’s 50 day moving average is $12.46 and its 200 day moving average is $12.12.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last released its quarterly earnings results on Thursday, May 4th. The software maker reported $0.10 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.09 by $0.01. The company had revenue of $415 million for the quarter, compared to analysts’ expectations of $415.20 million. Allscripts Healthcare Solutions had a positive return on equity of 5.75% and a negative net margin of 2.93%. The business’s quarterly revenue was up 20.1% compared to the same quarter last year. During the same period in the previous year, the business posted $0.13 earnings per share. On average, equities analysts anticipate that Allscripts Healthcare Solutions, Inc. will post $0.62 earnings per share for the current year.

TRADEMARK VIOLATION WARNING: This report was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this report on another domain, it was illegally stolen and republished in violation of U.S. and international trademark & copyright legislation. The original version of this report can be accessed at https://www.thecerbatgem.com/2017/08/03/paloma-partners-management-co-has-1-02-million-stake-in-allscripts-healthcare-solutions-inc-mdrx-updated-updated-updated.html.

Several equities research analysts have recently weighed in on MDRX shares. Zacks Investment Research raised shares of Allscripts Healthcare Solutions from a “sell” rating to a “hold” rating in a report on Wednesday, April 19th. Maxim Group reaffirmed a “buy” rating and issued a $16.00 target price on shares of Allscripts Healthcare Solutions in a report on Monday, May 15th. Piper Jaffray Companies reaffirmed a “hold” rating and issued a $14.00 target price on shares of Allscripts Healthcare Solutions in a report on Friday, July 21st. BidaskClub raised shares of Allscripts Healthcare Solutions from a “sell” rating to a “hold” rating in a report on Saturday, June 24th. Finally, Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $13.00 target price on shares of Allscripts Healthcare Solutions in a report on Monday, May 15th. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and ten have assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average price target of $14.74.

In other news, President Richard J. Poulton sold 25,000 shares of the business’s stock in a transaction dated Tuesday, May 16th. The stock was sold at an average price of $12.06, for a total transaction of $301,500.00. Following the sale, the president now directly owns 412,488 shares in the company, valued at $4,974,605.28. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 0.75% of the company’s stock.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

Institutional Ownership by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Stock Ratings for Allscripts Healthcare Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions Inc. and related stocks with our FREE daily email newsletter.